This week we highlight continued investment in virtual trials, robotic injections, costs of COVID-19 treatments and the need to understand drug safety for pregnant patients. Finally, we look at the most recent round of drug pricing reform in Congress which aims to reduce insulin prices. Each week we ... READ MORE >
Health care
5 things to know in life sciences: Week of March 14, 2022
This week we highlight patent infringement claims, ongoing manufacturing expansion, underrepresentation of pregnant women in clinical data, and the National Institutes of Health’s All of Us genomic study. Each week we highlight five things you need to know about in the life sciences industry. Here’s the ... READ MORE >
5 things to know in life sciences: Week of March 7, 2022
This week we highlight changes in drug exclusivity, international mRNA manufacturing expansion, clinical trial challenges in Russia, and recent Food and Drug Administration activities. Each week we highlight five things you need to know about in the life sciences industry. Here’s the latest. Top 10 ... READ MORE >
Along with community benefits, ESG efforts could reduce capital costs for health care providers
Health care executives and treasury departments may meaningfully engage in environmental, social and governance finance this year as we see ESG bonds and loans helping hospitals and health systems reduce capital costs in exchange for providers improving the health of their local communities—something they ... READ MORE >
5 things to know in life sciences: Week of Feb. 28, 2022
This week we highlight clinical holds on cell and gene therapies, clinical trials and patient experience, artificial intelligence and identifying bone fractures, and more. Each week we highlight five things you need to know about in the life sciences industry. Here’s the latest. Cell and gene therapies ... READ MORE >
5 things to know in life sciences: Week of Feb. 21, 2022
This week we highlight a personalized blood testing company, an artificial intelligence-based software platform capable of detecting heart disease and a promising mRNA technology that can heal bone defects. In addition, we look at a novel company providing a kidney care solution as well as Nintendo and ... READ MORE >
5 things to know in life sciences: Week of Feb. 14, 2022
This week, we highlight Moderna’s contract extension with Rovi, a recent report that indicates the global contract development and manufacturing organization (CDMO) market is expected to grow by over $8.65 billion by 2026, Robert Califf’s return as Food and Drug Administration commissioner, an artificial ... READ MORE >
5 things to know in life sciences: Week of Feb. 7, 2022
This week we highlight regulatory challenges for the United States and China; a softening of guidelines in the prescription of opioids; and record-breaking sales figures for Pfizer as it sees a more than 600% increase in vaccine revenue. Finally, we look at a new cartilage implant inspired by spiders and ... READ MORE >
5 things to know in life sciences: Week of Jan. 31, 2022
This week, we highlight a breakthrough tubeless insulin pump which received Food and Drug Administration clearance. We also look at a telehealth pharmacy booming during the pandemic, potential breakthroughs in neurovascular research, the disparity of Asian scientists’ contributions and recognition in ... READ MORE >
ESG’s growing impact on the health care industry: Spring 2022 outlook
Aside from the obvious benefits to community, culture and environment, another reason health care organizations are focused on ESG is to attract financing. Health care organizations will likely begin measuring and reporting ESG data as an evaluation tool for investors. Read about other outlook ... READ MORE >